1 The EIC Accelerator Project
EIC Accelerator Program Overview
The European Innovation Council (EIC) Accelerator is a pivotal funding initiative designed to support innovative startups and small to medium-sized enterprises (SMEs) within the European Union. Aimed specifically at high-risk, high-potential companies, the EIC Accelerator provides both grant funding and equity investment to catalyze the development and scaling of groundbreaking technologies and business models. The program is particularly focused on sectors considered critical for the European economy, including health, sustainability, and digital transformation.
Funding Structure
The EIC Accelerator offers a dual funding mechanism comprising grants and equity investments.
Purpose in the European Startup Ecosystem
The EIC Accelerator plays a vital role in enhancing the European DeepTech ecosystem by acting as a bridge between innovative startups and the private investment sector. It aims to reduce the funding gap that often exists for early-stage companies, particularly in high-tech and research-intensive fields. By providing substantial financial backing, the EIC Accelerator enables companies to develop their technologies and progress through the critical phases of commercialization and market entry.
Moreover, the program emphasizes fostering collaboration and knowledge transfer within the European innovation landscape. It encourages companies to engage with existing networks, including research institutions, corporate partners, and potential customers, thus enhancing their chances of success.
Support for Scaling and Private Sector Funding
The EIC Accelerator not only provides financial resources but also offers strategic guidance and mentorship. By connecting startups with experienced business leaders and industry experts, the program helps them navigate challenges associated with scaling their operations. This support is crucial for attracting further investment from private sectors, as companies that demonstrate a clear growth trajectory and a well-defined business model are more likely to secure additional funding from venture capitalists and angel investors.
Highlighting Strolll Limited and NavigAIt
Strolll Limited, a UK-based company, emerged as a winner in the EIC Accelerator program for its project, NavigAIt, submitted on June 21, 2023. NavigAIt is an innovative artificial intelligence (AI) application integrated into augmented reality (AR) glasses, specifically designed to assist individuals with Parkinson’s disease in their daily mobility.
Project Overview: NavigAIt
NavigAIt aims to provide intelligent, on-demand cueing to facilitate safe and confident walking for individuals with Parkinson’s. The application leverages advanced AI algorithms to analyze real-time data from the user, offering tailored prompts and guidance based on their specific needs. The goal is to mitigate the mobility challenges often faced by those with Parkinson’s, allowing them to navigate various environments with greater ease and independence.
Technology Basics and Background
NavigAIt is built upon a combination of AI, machine learning, and augmented reality technologies. The system utilizes sensors embedded in AR glasses to collect data on the user’s movements and surroundings. This data is processed using machine learning algorithms, which have been trained on vast datasets to recognize patterns associated with Parkinson’s-related mobility issues.
The AR component of the system overlays visual cues in the user’s field of vision, providing real-time guidance that can help in overcoming obstacles, maintaining balance, or simply encouraging forward motion. The integration of AI allows the system to learn and adapt to individual users over time, enhancing its effectiveness.
In conclusion, the EIC Accelerator program is a significant initiative in the European startup landscape, especially for DeepTech companies like Strolll Limited. By providing essential funding and support, the program fosters innovation that can transform lives, particularly for vulnerable populations like those living with Parkinson’s disease. The success of NavigAIt exemplifies the potential impact of such initiatives in addressing real-world challenges through cutting-edge technology.
2 The Funding Rounds
Strolll Limited: Financing and Funding Events Since EIC Accelerator Success
Overview
Strolll Limited, a UK-based neurorehabilitation software company leveraging augmented reality (AR) for therapeutic applications targeting neurological disorders, has experienced significant growth in financing and investor activity since its EIC Accelerator win following the June 21, 2023 cut-off.
Financing Raised & Funding Rounds
Summary of Funding Rounds
- Pre-EIC Accelerator (Early 2023):
- In April 2023, Strolll secured early-stage venture capital from SFC Capital and British Business Investments. The amount was not discloseddirectory.startupluxembourg.com.
- EIC Accelerator Grant (June 2023):
- Awarded a €2.5 million grant through the European Innovation Council (EIC) Accelerator programdirectory.startupluxembourg.com.
- Series A Round (March 2025):
- Raised €12.2 million (~£10.4–£10.3 million) in Series A funding led by IW Capitaleu-startups.com news.sky.com vestbee.com businesscloud.co.uk. This brought total disclosed funding to at least €23.6 million as of March 2025 when including equity and grantseu-startups.com.
Timing & Amounts
| Date | Round | Amount | Lead Investors |
|---|---|---|---|
| Apr 2023 | Early VC | Not disclosed | SFC Capital, BBI |
| Jun 21, 2023 | EIC Grant | €2.5 million | European Innovation Council |
| Mar 11–12, 2025 | Series A | €12.2 million (£10–£10.4m) | IW Capital |
Additional context: Strolll has also received a three-year £2.4 million project grant from the UK’s National Institute for Health and Care Research to conduct clinical trials with leading universities and NHS trustsnews.sky.com.
Investor Information
Notable Investors:
"We are delighted to be partnering with IW Capital... as we look to accelerate the growth of our business." — Jorgen Ellis, CEO of Strolll
Company Valuation
Recent estimates place Strolll Limited's enterprise value within several methodologies:
| Basis | Estimated Value |
|---|---|
| Turnover multiple | £1.9m |
| Net assets multiple | £3.4m |
Other calculations based on negative EBITDA suggest lower values; however, these figures do not reflect post-Series A valuations or recent revenue growth rates reported at over £1.6m annual turnover with rapid expansion—sales have grown at ~121% CAGR over three years up to December 2023pomanda.com.
A precise post-Series A valuation is not publicly available but would be expected to exceed previous multiples given recent investment scale.
Exit Events: IPOs or Acquisitions
As of May 6th, 2025:
There are no public records indicating that StrolL Limited has undergone an exit event such as an IPO or buyout/acquisition since its EIC Accelerator award.
However: Cleveland Clinic became a strategic shareholder during StrolL’s US market entry via IP transfer/licensing deal—this does not constitute an acquisition but is noteworthy as it involves equity participation by a major healthcare provider.
StrolL continues operating independently with strong backing from private investors and strategic partners.
Additional Information Related to Funding Rounds
Proceeds from recent rounds will be used: To accelerate sales and marketing activities To expand product development efforts For regulatory expansion targeting additional neurological disorders
This aligns closely with their strategy following successful clinical validation studies for their AR-based digital therapeutic platform designed for both clinic-based and home settings.
Sources
- Startup Luxembourg Directory – StrolL Profile
- EU Startups – Neuro-rehab software startup raises €12 .2M
- Sky News – Digital therapeutics group lands tonic of £1 OM
- Vestbee Blog – Stafford-based startup raises SeriesA
- BusinessCloud News – AR firm raising £104 m targets neuro disorders
- Pomanda Company Valuation Report –
Stro ll Limi ted
3 The Press Releases
Strolll Limited, based in the United Kingdom, has been making significant strides since receiving EIC Accelerator funding in June 2023. Here's an overview of the company's progress:Company Overview
Strolll is a digital therapeutic software company specializing in augmented reality (AR) solutions for neurorehabilitation. Their mission is to transform the lives of individuals with motor-disabling neurological disorders by developing intelligent digital therapeutics using AR glasses. This technology empowers movement in everyday life by blending digital content with the real world.Technology Advancements
Strolll's AR technology is designed to help patients with conditions such as Parkinson's disease, stroke, and Multiple Sclerosis. The company has developed the world's first clinically validated digital therapeutic software platform for neurorehabilitation, which utilizes off-the-shelf AR glasses to provide therapy.Partnerships and Collaborations
In 2023, Strolll entered into a significant collaboration with the Cleveland Clinic in the United States, resulting in a €2.7 million deal. This partnership included an exclusive software licensing agreement, with the Cleveland Clinic also becoming a shareholder in Strolll. Additionally, Strolll began a three-year project with the University of Leeds and the University of York, funded by a €2.8 million NIHR grant in July 2024.Funding Updates
Strolll received EIC Accelerator funding in June 2023 to further develop and commercialize its novel AR solution for cueing therapy in patients with neurological disorders. More recently, Strolll raised €12.2 million in a Series A funding round led by IW Capital, further positioning the company for growth in the neurorehabilitation market.Team Updates
Jorgen Ellis serves as the CEO of Strolll, joining the company in 2020. Ellis previously founded Flatpack Global at the age of 17 and exited the company in 2019 after securing large partnerships with IKEA.Press Releases and Social Media
While specific press releases from Strolll's website or social media accounts are not detailed in the available information, the company's funding announcements and partnerships have been covered by various media outlets. Strolll's growth and innovative technology in the neurorehabilitation sector have garnered significant attention, reflecting its potential impact on healthcare.Sources: - EIC Accelerator winners and statistics June 2023
- Behind an EIC winner: Strolll's Revolutionary Rehabilitation Software
- Neuro-rehab software startup Strolll raises €12.2 million for AR glasses
4 The Technology Advancements
Overview of Strolll Limited
Strolll Limited, a UK-based company, is a pioneer in digital therapeutic software for augmented reality (AR) glasses, focusing on neurorehabilitation for patients with neurological disorders such as Parkinson's disease, stroke, and multiple sclerosis. Their innovative approach combines digital content with real-world environments to enhance patient care both in clinics and at home.
Current Capabilities
Strolll's technology seamlessly integrates with commercially available AR glasses, providing a patient-centered solution that adapts to diverse patient needs. The platform allows for synchronous or asynchronous therapy sessions, capturing clinically relevant data and enabling remote monitoring. This approach has shown significant improvements in mobility for patients struggling with walking or balance, while also reducing the administrative burden on clinicians.
Advancements Since June 2023
Although specific details about advancements since receiving EIC Accelerator funding on June 21, 2023, are not directly mentioned, Strolll has continued to make significant strides in the neurorehabilitation market. In March 2025, the company secured a substantial Series A investment of £10.35 million, led by IW Capital, which will be used to accelerate sales and marketing, extend product leadership, and expand its regulatory label to target additional neuro-related disorders.
Technology and Market Demonstration
Strolll has effectively demonstrated its technology through clinical trials, including a notable NIHR-funded project with leading NHS trusts to study its efficacy in treating Parkinson’s disease. This project began in July 2024 and is set to report findings by April 2025. The company's technology has been well-received, with results showing improved treatment outcomes and efficiency in healthcare delivery.
New Features and Patents
While specific new features or patents filed since June 2023 are not detailed, Strolll continues to develop its platform with a clinician-led approach to game design, ensuring maximum rehabilitation impact. The company has seven games currently available, with more in development.
Clinical Trials and Scientific Studies
Strolll's clinical trials have demonstrated the effectiveness of its AR-based rehabilitation, showing significant improvements in patient mobility and adherence to rehabilitation programs. These trials have also highlighted the efficiency gains for healthcare providers, allowing for more treatments with reduced staff time.
Conclusion
Strolll Limited has positioned itself as a leader in neurorehabilitation by leveraging AR technology to enhance patient care. Despite the lack of specific information on advancements since the EIC Accelerator funding, the company's recent investment and ongoing clinical trials underscore its commitment to innovation and expansion in the neurorehabilitation sector.
Sources
- Strolll: Home page
- Neuro-rehab software startup Strolll raises €12.2 million for AR ...
- Strolll - Reality DTx - Health Innovation East
- Strolll secures £10.35 million Series A Investment led by IW Capital
- £10m boost for augmented reality glasses to help gamify physio
- Stroll secures £10.3m of funding - Martlet Capital
- Advising IW Capital Ltd as the lead investor in a £10.35m investment ...
- Behind an EIC winner: Strolll's Revolutionary Rehabilitation Software
5 The Partnerships and Customers
Strolll Limited: Partnerships and Growth Since EIC Accelerator Funding
Strolll Limited, a UK-based company specializing in digital therapeutic software for augmented reality (AR) glasses, has made significant strides since receiving EIC Accelerator funding in June 2023. The company's innovative approach to neurorehabilitation, particularly for conditions like Parkinson's disease and Multiple Sclerosis, has garnered substantial attention and investment.
Existing Partnerships
- Cleveland Clinic: Strolll entered the US market with a €2.7 million collaboration with the Cleveland Clinic, which also became a shareholder. This partnership involved an exclusive software licensing agreement, enhancing Strolll's presence in the US healthcare sector.
- Health Innovation East: This organization has provided Strolll with mentoring, market entry advice, and connections to key NHS colleagues. They also supported Strolll in securing a successful NIHR grant application.
- Martlet Capital: Martlet first invested in Strolll during its seed round in 2023 and has been actively involved on the company's board.
New Partnerships
Strolll's recent funding round was led by IW Capital, a leading investment house specializing in growth capital for UK SMEs. This partnership is crucial for accelerating Strolll's sales and marketing activities and expanding its product range.
New Customers
While specific new customer names are not disclosed, Strolll's expansion into the US market and its ongoing clinical trials suggest an increase in customer base across various healthcare providers and patients with neurological disorders.
Nature of New Relationships
The new relationships are primarily focused on strategic investments and partnerships that enhance Strolll's market presence and technological capabilities. The partnership with IW Capital and the collaboration with Cleveland Clinic underscore Strolll's commitment to spreading its innovative AR-based neurorehabilitation solutions globally.
Market Positioning
Strolll's new relationships are positioning the company as a leader in the neurorehabilitation market, particularly in the use of AR technology. This positioning is crucial as the healthcare segment of the AR market is expected to grow rapidly, providing Strolll with a competitive edge in addressing key healthcare needs.
Technology Advancements and Scaling
The partnerships and investments are facilitating Strolll's technology advancements by supporting the development of more sophisticated AR-based rehabilitation tools. Additionally, these relationships are enabling Strolll to scale its operations more effectively, both domestically and internationally, through expanded sales and marketing efforts.
Sources
- Stroll secures £10.3m of funding - Martlet Capital martletcap.com
- Strolll: Home page strolll.co
- Strolll - Reality DTx - Health Innovation East healthinnovationeast.co.uk
- Strolll: Augmented Reality Rehabilitation - Browne Jacobson LLP brownejacobson.com
- Neuro-rehab software startup Strolll raises €12.2 million for AR glasses eu-startups.com
- £10 million funding boost for digital therapeutic start-up healthinnovationeast.co.uk
6 The Hiring and Company Growth
Strolll Limited: Growth and Development Post-EIC Accelerator Funding
Strolll Limited, a UK-based neuro-rehabilitation software startup, received EIC Accelerator funding in June 2023. Since then, the company has experienced significant growth, marked by strategic investments and innovative advancements in the healthcare sector.
Team Size and Hiring
As of the latest available information, Strolll Limited employs 35 staff members. This number reflects the company's expansion following its recent funding rounds. While specific details about current hiring processes or open positions are not immediately available, the growth in staff size indicates a positive trend in team development.
Funding and Growth
Strolll Limited raised €12.2 million in a Series A funding round in March 2025, led by IW Capital. This investment highlights the company's potential in the neuro-rehabilitation market, where it is pioneering the use of augmented reality (AR) glasses for treating neurological disorders such as Parkinson's disease, stroke, and Multiple Sclerosis. The company has received a total of €23.6 million in equity and grant funding to date.
Key Positions and Recent Hires
There is no specific information available about recent key hires. However, the company's growth and funding suggest that it is actively expanding its team to support its innovative digital therapeutic software platform.
Impact of New Team Members
The addition of new team members will be crucial for Strolll Limited as it aims to scale and grow. By expanding its workforce, the company can enhance its capabilities in developing and deploying its AR-based rehabilitation solutions more effectively. This growth will likely contribute to increased market presence and penetration, particularly in the healthcare sector.
Management and Founding Team
Strolll Limited was founded by Tom Finn in 2019, with Jorgen Ellis joining as Co-founder and CEO in 2020. Jorgen Ellis, previously the founder of Flatpack Global, brings significant entrepreneurial experience to the role. There are no reported major changes in the management or founding team that have been publicly disclosed since receiving the EIC Accelerator funding.
Future Prospects
With its cutting-edge technology and strategic investments, Strolll Limited is well-positioned to transform the physiotherapy and neuro-rehabilitation markets. The company's focus on patient-centered therapy using AR glasses offers a unique approach to rehabilitation, making it a leader in this rapidly evolving field.
Sources: - Strolll: Home page
- Neuro-rehab software startup Strolll raises €12.2 million for AR glasses
7 The Media Features and Publications
Strolll Limited: A Revolutionary Neurorehabilitation Startup
Introduction
Strolll Limited, a UK-based startup, has been making waves in the neurorehabilitation sector with its innovative augmented reality (AR) solutions. After receiving funding from the European Innovation Council (EIC) Accelerator in June 2023, Strolll has continued to grow and expand its presence in the healthcare industry.
Media Features and Publications
Strolll has been featured in several publications, highlighting its groundbreaking AR-based therapy software for neurological mobility. Notably, Strata's blog has discussed Strolll's journey and success with the EIC Accelerator, emphasizing its revolutionary rehabilitation software designed to help individuals with neurological disorders like Parkinson’s disease, stroke, and Multiple Sclerosis. Additionally, EU Startups and Vestbee have covered Strolll's recent funding rounds, including a €12.2 million Series A investment led by IW Capital, aimed at advancing its digital therapeutics platform.
Podcasts and Interviews
While there is no specific mention of podcasts, Strolll's co-founder Jorgen Ellis has shared insights into the company's journey and its experience with the EIC Accelerator in interviews. These discussions highlight Strolll's mission to transform the lives of people living with motor-disabling neurological disorders through cutting-edge AR technology.
Conference and Fair Visits, Presentations
There is no detailed information available about Strolll's specific participation in conferences and fairs. However, given its involvement in the EIC Accelerator and its impact in the neurorehabilitation market, it is likely that Strolll engages in industry events to showcase its technology and collaborate with other innovators.
Event Involvement
Strolll's involvement in events is closely tied to its growth strategy and partnerships. For example, its collaboration with the Cleveland Clinic in a €2.7 million deal demonstrates its active participation in strategic partnerships and potentially related events within the healthcare sector.
Conclusion
Strolll Limited has emerged as a leader in neurorehabilitation, leveraging AR technology to improve the lives of individuals with neurological disorders. With substantial funding and strategic partnerships, Strolll continues to innovate and expand its influence globally.
Sources
Do you need EIC Accelerator support?
Here is a list of the key service options for the EIC Accelerator:
Full Writing Service
All proposal sections are written by Stephan Segler, PhD.
Advisory Service
You write in-house but receive 1-on-1 support, templates, instructions, and reviews of all documents.
AI Writer & Training
A high-quality AI writer for EIC Accelerator Step 1 and a comprehensive Training program for Steps 1 and 2 including all templates and instructions.